IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+14.44%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$257M
AUM Growth
+$257M
(-2.4%)
Cap. Flow
-$21M
Cap. Flow
% of AUM
-8.18%
Top 10 Holdings %
Top 10 Hldgs %
53.62%
Holding
74
New
14
Increased
16
Reduced
17
Closed
18
Top Buys
1 |
Alnylam Pharmaceuticals
ALNY
|
$4.85M |
2 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$4.33M |
3 |
Sangamo Therapeutics
SGMO
|
$4.1M |
4 |
Neurocrine Biosciences
NBIX
|
$4.04M |
5 |
Acadia Pharmaceuticals
ACAD
|
$3.88M |
Top Sells
1 |
Vertex Pharmaceuticals
VRTX
|
$7.11M |
2 |
Viatris
VTRS
|
$5.43M |
3 |
SHPG
Shire pic
SHPG
|
$5.4M |
4 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$5.01M |
5 |
BioMarin Pharmaceuticals
BMRN
|
$4.63M |
Sector Composition
1 | Healthcare | 91.46% |